

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 9, 26 | Sugla Vishwas | officer: Chief Strategy Officer | A-Award | 2,073 | — |
| Sep 9, 26 | Sugla Vishwas | officer: Chief Strategy Officer | A-Award | 2,827 | — |
| Sep 9, 26 | Sugla Vishwas | officer | 0 | — | |
| Sep 3, 26 | Desilva Joseph | officer: Executive VP | S-Sale | 631 @ $282.87 | $178.5K |
| Sep 1, 26 | Rodriguez Carlos A | director | F-InKind | 13,472 @ $283.49 | $3.82M |
| Sep 1, 26 | Orihuela Samantha D | officer: Chief Marketing Officer | A-Award | 1,163 | — |
| Sep 1, 26 | Orihuela Samantha D | officer: Chief Marketing Officer | F-InKind | 154 @ $283.49 | $43.69K |
| Sep 1, 26 | Michaud Brian L. | officer: Executive VP | A-Award | 2,683 | — |
Current price $287.03
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
FY2026 · 10-K disclosure
FY2026 · 10-K disclosure
Stock news · updated daily
I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data points per stock, highlight 12 undervalued and 18 fairly valued Aristocrats, with 39 currently overvalued. Investment candidates vary by style: ADP, BRO, and NDSN for growth; NEE for total return; PEP and O for income; CAT and GWW for past performance.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for ADP (ADP), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
| Aug 5, 26 |
| Cantor Fitzgerald |
| maintain |
| Overweight |
| Overweight |
| Aug 3, 26 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Jul 30, 26 | Stifel | maintain | Hold | Hold |
| Jul 30, 26 | Guggenheim | maintain | Buy | Buy |
| Jul 30, 26 | Citigroup | maintain | Neutral | Neutral |
| Jul 30, 26 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Jul 30, 26 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Jul 22, 26 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Jul 22, 26 | UBS | maintain | Neutral | Neutral |
| 3 | Sep 10, 2026 | 2026-09-10 16:05:26 | View |
| 4 | Sep 4, 2026 | 2026-09-04 16:07:22 | View |
| 4 | Sep 3, 2026 | 2026-09-03 16:07:09 | View |
| 4 | Sep 3, 2026 | 2026-09-03 16:07:07 | View |
| 4 | Sep 3, 2026 | 2026-09-03 16:07:04 | View |
| 4 | Sep 3, 2026 | 2026-09-03 16:07:02 | View |
Proxy statement (DEF 14A) disclosures
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | 2.59 | 2.64 | Beat 1.9% | $5.47B |
| Apr 29, 2026 | 3.30 | 3.37 | Beat 2.1% | $5.94B |
| Jan 28, 2026 | 2.57 | 2.62 | Beat 1.9% | $5.36B |
| Oct 29, 2025 | 2.44 | 2.49 | Beat 2.0% | $5.18B |
| Jul 30, 2025 | 2.23 | 2.26 | Beat 1.3% | $5.13B |
| Apr 30, 2025 | 2.97 | 3.06 | Beat 3.0% | $5.55B |
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-19
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 68.16 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 91.71 | Oscillator | Sell |
| Williams %R (14) | -9.05 | Oscillator | Sell |
| MACD (12, 26, 9) | 4.04 (Hist 2.95) | Oscillator | Strong Buy |
| Average Directional Index (14) | 24.05 (+DI 35.9 / -DI 13.7) | Trend | Buy |
TTM vs. 5-year historical average (annual ratios)
| Metric | ADP | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 26.2x | 26.7x · sector 44.2x | Discount |
| Forward P/E (FY27E) | 23.4x | EPS est. 12.26 | In line |
| Price / Book | 19.0x | 21.9x | In line |
| Price / Sales | 5.2x | 5.1x | In line |
| EV / EBITDA | 17.8x | 18.0x | In line |
| Return on equity | 70.2% | — | Top tier |
| Gross margin | 48.2% | 48.9% | In line |
| Debt / Equity | 0.87 | 1.04 | Moderate |
| Piotroski / Altman Z | 6/9 | Z 1.66 | Distress |
Discounted cash flow model
| EMA 20 | 273.89 | MA | Strong Buy |
| SMA 20 | 269.16 | MA | Strong Buy |
| EMA 50 | 268.81 | MA | Strong Buy |
| SMA 50 | 273.18 | MA | Strong Buy |
| SMA 200 | 238.79 | MA | Strong Buy |